Investors
Latest results
From quarterly updates to key announcements, here you can access all GSK investor-related information.
Scroll to explore
We’re confident in our future
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.
Latest announcements and results
Speeches and presentations
Dividend and share price
Explore our innovation stories

Unlocking the power of the immune system to get ahead of hepatitis B

Tackling tomorrow’s health challenges today

How vaccine science can help tackle antimicrobial resistance

The 40 year fight against HIV

How the next generation of immuno-oncology could help us get ahead of cancer

1.4 million reasons to get ahead of gynaecologic cancers

Digital twin: using advanced technology to accelerate vaccine development

What if remission were the target of lupus care?

Synthetic Lethality: accelerating precision cancer treatments

Tech for T-cells single cell RNA seq measures shifts in immune cells to pinpoint causes of disease
Shareholder information
Shareholder information